ArticleMedicine2025

Refractory immune thrombocytopenia treated with low-dose decitabine combined with recombinant human thrombopoietin or eltrombopag: Two case reports.

Yuxia Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.